NM_004136.4:c.2472+12A>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004136.4(IREB2):c.2472+12A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.995 in 1,613,748 control chromosomes in the GnomAD database, including 798,977 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.97 ( 72065 hom., cov: 32)
Exomes 𝑓: 1.0 ( 726912 hom. )
Consequence
IREB2
NM_004136.4 intron
NM_004136.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.00800
Publications
9 publications found
Genes affected
IREB2 (HGNC:6115): (iron responsive element binding protein 2) The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
IREB2 Gene-Disease associations (from GenCC):
- neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemiaInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 15-78494068-A-C is Benign according to our data. Variant chr15-78494068-A-C is described in ClinVar as Benign. ClinVar VariationId is 1300042.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IREB2 | NM_004136.4 | c.2472+12A>C | intron_variant | Intron 19 of 21 | ENST00000258886.13 | NP_004127.2 | ||
| IREB2 | NM_001320942.2 | c.2301+12A>C | intron_variant | Intron 19 of 21 | NP_001307871.2 | |||
| IREB2 | NM_001354994.2 | c.2301+12A>C | intron_variant | Intron 19 of 21 | NP_001341923.2 | |||
| IREB2 | NM_001320941.2 | c.1722+12A>C | intron_variant | Intron 18 of 20 | NP_001307870.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IREB2 | ENST00000258886.13 | c.2472+12A>C | intron_variant | Intron 19 of 21 | 1 | NM_004136.4 | ENSP00000258886.8 | |||
| IREB2 | ENST00000558570.5 | n.*1739+12A>C | intron_variant | Intron 18 of 20 | 1 | ENSP00000454063.1 | ||||
| IREB2 | ENST00000559091.1 | c.-143A>C | upstream_gene_variant | 3 | ENSP00000453863.1 |
Frequencies
GnomAD3 genomes AF: 0.972 AC: 147871AN: 152156Hom.: 72013 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
147871
AN:
152156
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.993 AC: 248393AN: 250114 AF XY: 0.995 show subpopulations
GnomAD2 exomes
AF:
AC:
248393
AN:
250114
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.997 AC: 1457464AN: 1461474Hom.: 726912 Cov.: 46 AF XY: 0.998 AC XY: 725311AN XY: 727036 show subpopulations
GnomAD4 exome
AF:
AC:
1457464
AN:
1461474
Hom.:
Cov.:
46
AF XY:
AC XY:
725311
AN XY:
727036
show subpopulations
African (AFR)
AF:
AC:
30182
AN:
33440
American (AMR)
AF:
AC:
44427
AN:
44628
Ashkenazi Jewish (ASJ)
AF:
AC:
26105
AN:
26106
East Asian (EAS)
AF:
AC:
39678
AN:
39678
South Asian (SAS)
AF:
AC:
86204
AN:
86214
European-Finnish (FIN)
AF:
AC:
53414
AN:
53414
Middle Eastern (MID)
AF:
AC:
5738
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1111721
AN:
1111852
Other (OTH)
AF:
AC:
59995
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
190
380
569
759
949
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21668
43336
65004
86672
108340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.972 AC: 147983AN: 152274Hom.: 72065 Cov.: 32 AF XY: 0.974 AC XY: 72488AN XY: 74444 show subpopulations
GnomAD4 genome
AF:
AC:
147983
AN:
152274
Hom.:
Cov.:
32
AF XY:
AC XY:
72488
AN XY:
74444
show subpopulations
African (AFR)
AF:
AC:
37393
AN:
41510
American (AMR)
AF:
AC:
15182
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
3470
AN:
3470
East Asian (EAS)
AF:
AC:
5188
AN:
5188
South Asian (SAS)
AF:
AC:
4826
AN:
4826
European-Finnish (FIN)
AF:
AC:
10616
AN:
10616
Middle Eastern (MID)
AF:
AC:
294
AN:
294
European-Non Finnish (NFE)
AF:
AC:
68024
AN:
68038
Other (OTH)
AF:
AC:
2078
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
199
398
597
796
995
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
914
1828
2742
3656
4570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3455
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemia Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.